These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2243571)

  • 1. Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation.
    Dumann H; Meuer SC; Köhler H
    Nephron; 1990; 56(2):162-5. PubMed ID: 2243571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressive fraction isolated from uremic ultrafiltrates: attempted characterization of the mechanism of action.
    Navarro J; Grossetête MC; Touraine JL; Traeger J
    Adv Exp Med Biol; 1987; 223():157-60. PubMed ID: 3128939
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered monocyte function in uremia.
    Gibbons RA; Martinez OM; Garovoy MR
    Clin Immunol Immunopathol; 1990 Jul; 56(1):66-80. PubMed ID: 2192826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses.
    Donati D; Degiannis D; Raskova J; Raska K
    Kidney Int; 1992 Sep; 42(3):681-9. PubMed ID: 1405346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies in uremic and kidney transplanted patients.
    Langhoff E
    Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory cell functions in mononuclear cell cultures uremic patients.
    Ladefoged J; Langhoff E
    Kidney Int; 1990 Jan; 37(1):126-30. PubMed ID: 2299798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number.
    Stachowski J; Pollok M; Burrichter H; Spithaler C; Baldamus CA
    Nephron; 1993; 64(3):369-75. PubMed ID: 8101978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.
    Meuer SC; Hauer M; Kurz P; Meyer zum Büschenfelde KH; Köhler H
    J Clin Invest; 1987 Sep; 80(3):743-9. PubMed ID: 3497950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis.
    Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F
    Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL; Bloemmen FJ; Van Wauwe JP
    J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.
    Baroja ML; Ceuppens JL; Van Damme J; Billiau A
    J Immunol; 1988 Sep; 141(5):1502-7. PubMed ID: 3261751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-mediated suppression of mitogen responses of lymphocytes in uremic patients.
    Osaki K; Otsuka H; Uomizu K; Harada R; Otsuji Y; Hashimoto S
    Nephron; 1983; 34(2):87-92. PubMed ID: 6602948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derangement of humoral immune system in nondialyzed uremic patients.
    Kamata K; Okubo M
    Jpn J Med; 1984 Feb; 23(1):9-15. PubMed ID: 6379244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition.
    Stachowski J; Pollok M; Barth C; Maciejewski J; Baldamus CA
    Nephrol Dial Transplant; 1994; 9(2):144-52. PubMed ID: 7910675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients.
    Lim WH; Kireta S; Leedham E; Russ GR; Coates PT
    Kidney Int; 2007 Nov; 72(9):1138-48. PubMed ID: 17728708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.
    Girndt M; Sester M; Sester U; Kaul H; Köhler H
    Kidney Int; 2001 Apr; 59(4):1382-9. PubMed ID: 11260399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
    Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release.
    Donati D; Degiannis D; Homer L; Gastaldi L; Raskova J; Raska K
    Nephron; 1991; 58(3):268-75. PubMed ID: 1896091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.